<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Q318 SCS Market Recap: On Track for Another Record Year

Posted by Anne Staylor on 1/21/19 10:17 AM

New Products, Continued Demand Provide SCS Market Tailwinds

SmartTRAK reports that with new products providing a strong tailwind in Q318, the SCS market saw another quarter of strong double-digit growth in both the US and WW, positioning the market for another record year. 

Among the many topics covered in the Q318 SCS Market Recap are:

Read More

Topics: Neuromodulation-Spinal Cord Stimulation, Q318 Market Recaps

Spinal Cord Stimulation: Top Trends to Watch in 2019 and Beyond

Posted by Anne Staylor on 1/15/19 12:00 PM

SmartTRAK identifies trends to watch in spinal cord stimulation 

With the start of a new year, it's time to look back at 2018 and identify continuing and emerging trends in the market for Spinal Cord Stimulation (SCS) that are likely to shape the landscape in 2019 and beyond.

So what’s on the horizon? Anne Staylor, SmartTRAK Managing Editor, gives her predictions for the top technology and market trends to watch.

Among the many interesting and informative topics covered in the article are:

Read More

Topics: Neuromodulation-Spinal Cord Stimulation

An Interview with Medtronic's Matt Thomas

Posted by Anne Staylor on 11/6/18 11:00 AM

Medtronic’s Matt Thomas discusses the Company’s strategies for driving growth in spinal cord stimulation and plans for innovation in an interview with SmartTRAK at ASIPP 2018.

Matt Thomas, General Manager and Vice President of Medtronic’s STIM & Early Intervention business discusses the Company’s growth strategies, plans for innovation, and what’s next in spinal cord stimulation in a podcast interview with SmartTRAK at the American Society of Interventional Pain Physicians (ASIPP) 2018 held March 15-17, 2018 in Orlando, FL

Click the Podcast Link to hear the interview, recorded live at ASIPP 2018. (18:55 minutes.)

To receive a downloadable transcript, click the button below...

Read More

Topics: Neuromodulation-Spinal Cord Stimulation, SmartTRAK Interviews

SmartTRAK Publication Alert: US Spinal Cord Stimulation Market Recap

Posted by Anne Staylor on 6/25/18 11:32 PM

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 US Spinal Cord Stimulation Market Recap.

The US Spinal Cord Stimulation (SCS) market saw another quarter of exceptional growth in Q118, yet the market decelerated QoQ, posting 23% growth vs 24.6% growth in Q417. While seasonal trends were behind the QoQ slowdown ...

Among the many topics covered in the full Q118 SCS Market Recap are: 

Read More

Topics: Neuromodulation-Spinal Cord Stimulation

A Look Back: The One to Beat, Nevro's Growth Strategies and Challenges

Posted by Anne Staylor on 6/18/18 4:37 PM

In May 2017, Nevro CEO Rami Elghandour chatted with Anne Staylor, BioMedGPS Managing Editor/Neuro Analyst to discuss dynamics in the global spinal cord stimulation (SCS) market, including trends, drivers, challenges, competition, and opportunity that would influence the Company’s growth. 

A fascinating read then, that now has us appraising a year later if Elghandour's expansion predictions came to pass. Is Nevro still the one to beat as the top leader in the neuromodulation field?

Register to download PDF or read the interview in full below!

Read More

Topics: Neuromodulation, Neurotherapies, Neuromodulation-Spinal Cord Stimulation

Strategies in Stroke Care:  Interview with Medtronic's Stacey Pugh

Posted by Anne Staylor on 6/11/18 2:28 PM

Medtronic’s Stacey Pugh discusses the Company’s new Riptide Aspiration System, new products in development, and growth strategies for the neurovascular business in a podcast interview with SmartTRAK at the International Stroke Conference (ISC) 2018 held Jan. 24-26, 2018 in Los Angeles, CA.

Anne Staylor here with BioMedGPS. We're at the International Stroke Conference in Los Angeles, and today I'm talking with Stacey Pugh of Medtronic Neurovascular. Hi Stacey, thanks for joining me.

Read More

Topics: Neuromodulation-Spinal Cord Stimulation

phenox Aiming To Bring Novel Stroke Devices to the US Market

Posted by Anne Staylor on 6/8/18 3:52 PM

In the market for stroke devices, Europe seems to be the proving ground for next generation devices, and several companies with novel technologies are emerging from Europe that could potentially reach the US market in the next several years. One European company taking aim at the US market is Bochum, Germany-based phenox GmbH.

Read More

Topics: Neuromodulation-Spinal Cord Stimulation, SmartTRAK Interviews

SmartTRAK'S Final 2017 Spinal Cord Stimulation Market Financial Results

Posted by Anne Staylor on 4/9/18 12:27 PM

The US Spinal Cord Stimulation market reached new heights in Q417/FY17, driven by new products, expanding indications, and a growing demand for non-narcotic alternatives for treating chronic intractable pain. 

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its 2017 US Spinal Cord Stimulation Market Recap and Financial Dashboard.

Among the many topics covered in the Q417/FY17 Spinal Cord Stimulation Market Recap are:

Read More

Topics: Neuromodulation-Spinal Cord Stimulation

High Frequency SCS for Upper Limb and Neck Pain: An Interview with Kas Amirdelfan, MD

Posted by Anne Staylor on 1/18/18 11:33 AM

Kas Amirdelfan, MD talked with SmartTRAK at the ASRA 2017 Annual Meeting regarding preliminary 12 month results from the SENZA-ULN study

Kas Amirdelfan, MD, principle investigator of the SENZA-Upper Limb and Neck (ULN) study, spoke with SmartTRAK's Anne Staylor at the recent American Society of Regional Anesthesia and Pain Medicine (ASRA) annual meeting in Lake Buena Vista, FL regarding preliminary 12 month results from SENZA-ULN, the unmet clinical need for chronic intractable ULN pain, factors affecting physician adoption for this indication and what’s next for this research. (See ASRA Poster 4194.) 

A transcript of SmartTRAK’s interview with Dr. Amirdelfan is below or click on the following video to view the interview recorded live at ASRA 2017. (13:23 minutes.)

Read More

Topics: Neuromodulation-Spinal Cord Stimulation, SmartTRAK Interviews

SmartTRAK Attending NANS 2018

Posted by Anne Staylor on 1/8/18 6:32 PM

 

SmartTRAK is excited to be attending NANS 2018 - the North American Neuromodulation Society's 21st Annual Meeting meeting on Jan 11-14, 2018 at Caesars Palace in Las Vegas, Nevada.

Read More

Topics: Neuromodulation-Spinal Cord Stimulation, SmartTRAK Conferences

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts